Dilip Mahalanabis

Anyone asking who was Dilip Mahalanabis should begin in Kishoreganj, a district town in the Bengal of British India, where he was born on November 12, 1934 ^[1]. The region is now part of Bangladesh, a fact that would carry a certain symmetry decades later, when his most famous work saved the lives of refugees fleeing the war that created that country.

His family, like many Bengali Hindu households of the period, was oriented toward education and professional life. Mahalanabis moved to Calcutta for his medical training, studying at the Calcutta Medical College and completing further clinical work in the city's teaching hospitals ^[2]. Calcutta in the 1950s was a hard school for a young doctor: cholera and other diarrhoeal diseases were endemic, wards were crowded, and the gap between what medicine could do in theory and what it could deliver to the poor was obvious every day.

He pursued specialist training abroad, working in paediatrics in London, where he held posts at the Queen Elizabeth Hospital for Children and became one of the early Indian doctors to serve as a registrar there ^[2]. The combination of Bengali clinical experience and British paediatric training shaped the direction of his career: he returned to India focused on children's medicine and on the diseases of poverty.

In the 1960s Mahalanabis joined the Johns Hopkins University Center for Medical Research and Training in Calcutta, a unit that studied cholera and other enteric infections in the environment where they did the most damage ^[3]. There he entered a small international community of researchers, including American scientists such as David Nalin and Richard Cash working in Dhaka, who were converging on a deceptively simple idea.

The idea rested on a physiological discovery: glucose enhances the absorption of sodium and water across the lining of the intestine, even in a gut ravaged by cholera toxin ^[3]. If that was true, a patient losing litres of fluid through diarrhoea might be kept alive by drinking a correctly proportioned solution of glucose and salts, rather than depending on sterile intravenous fluid, trained staff, and hospital beds. Early clinical studies in Dhaka and Calcutta in 1968 and 1969 suggested the approach worked under controlled conditions ^[4].

What nobody had shown was that oral rehydration solution could work outside a research ward, administered by untrained hands in chaotic conditions. Many physicians remained skeptical, worried that imprecise mixing would produce dangerously salty solutions or that severely dehydrated patients could never drink enough. Mahalanabis was about to run the experiment that settled the question, though not by choice.

When the Pakistani army began its crackdown in East Pakistan in March 1971, millions of refugees poured across the border into Indian West Bengal. Cholera travelled with them. At the camps around Bangaon, near the frontier, Mahalanabis and a small team from the Johns Hopkins centre found thousands of patients, a fatality rate approaching 30 percent among the cholera cases, and a supply of intravenous fluid that was nowhere near sufficient ^[4]. Only two members of his team were trained to give IV therapy at all.

His response became one of the most cited decisions in modern public health. Mahalanabis had drums filled with a solution of table salt, baking soda, and commercial glucose, dissolved in water in fixed proportions, and instructed relatives and volunteers to keep patients drinking it constantly. The treatment was pushed out of the treatment tents entirely: mothers, siblings, and untrained helpers became the delivery system ^[5].

The results were unambiguous. Over roughly eight weeks the case fatality rate among cholera patients treated in the camps fell to around 3 percent, far below what conventional wisdom said was possible without intravenous therapy ^[4]. Some 3,700 patients were treated with the oral solution. Mahalanabis published the findings with colleagues in the Johns Hopkins Medical Journal in 1973, providing the first large-scale field evidence that oral rehydration therapy worked in a real emergency ^[5].

Any honest list of Dilip Mahalanabis achievements starts with that demonstration, because of what followed from it. The World Health Organization and UNICEF, initially cautious, adopted oral rehydration therapy (ORT) as the frontline treatment for diarrhoeal dehydration, and from 1978 promoted a standard packet of oral rehydration salts worldwide ^[6]. The Lancet later described ORT as potentially the most important medical advance of the twentieth century, and estimates commonly credit the therapy with preventing more than 50 million deaths, most of them children ^[6].

Mahalanabis spent much of the following two decades embedding the therapy in global practice. He worked with the WHO on cholera control in Afghanistan, Egypt, and Yemen during the 1970s, and from 1975 to 1979 served in the organisation's diarrhoeal diseases control programme ^[3]. In the 1980s he continued clinical research on enteric disease, and in the 1990s he served as director of clinical research at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) in Dhaka, the institution that grew out of the old Cholera Research Laboratory ^[3].

Recognition arrived slowly, then generously. In 2002 he shared the first Pollin Prize for Pediatric Research, awarded through NewYork-Presbyterian Hospital, with Nathaniel Pierce, David Nalin, and Norbert Hirschhorn for the development of ORT ^[7]. In 2006 he received Thailand's Prince Mahidol Award in public health, again alongside colleagues from the oral rehydration story ^[8]. In January 2023, months after his death, the Government of India conferred on him the Padma Vibhushan, the country's second highest civilian honour ^[1].

Colleagues who assembled the basic Dilip Mahalanabis facts after his death kept returning to the same theme: a man of unusual modesty who never sought credit proportional to his impact. He gave few interviews, avoided public platforms, and lived quietly in Kolkata with his wife, Jayanti ^[2]. Journalists who profiled him late in life noted that he remained little known even in his own city, despite the global reach of the therapy he had validated.

He did, however, act on his convictions with his own money. Mahalanabis was closely associated with the Institute of Child Health in Kolkata, where he had trained early in his career, and he and his wife donated their savings, reported at one crore rupees, to support paediatric research and care there ^[2]. The gesture was characteristic: practical, local, and directed at children.

Those who worked with him described a rigorous clinical scientist rather than a romantic hero. He was insistent that the 1971 intervention was not improvisation for its own sake but the application of physiology that he and others had already tested; the camps simply forced the scale ^[4].

After returning from Dhaka in the mid 1990s, Mahalanabis settled back into Kolkata and continued to advise on child health and nutrition research, including work associated with the Society for Applied Studies, a research group focused on maternal and child health ^[3]. He watched oral rehydration therapy become so ordinary that its origins were largely forgotten: ORS packets sold in village shops, mothers taught the recipe in primary health centres, a treatment costing a few cents administered billions of times.

His health declined in his late eighties. Dilip Mahalanabis died on October 16, 2022, in a Kolkata hospital, where he had been treated for a lung infection and related complications. He was 87 ^[1]. Obituaries appeared in The Lancet, The BMJ, and major Indian and international newspapers, most of them making the same observation: few physicians in history had a stronger claim to having saved millions of lives while remaining almost unknown to the public ^[6].

The posthumous Padma Vibhushan announced on the eve of India's Republic Day in 2023 prompted a fresh round of attention, and with it some national self-examination about why the honour had not come during his lifetime ^[1].

The core of any Dilip Mahalanabis biography is a single, transferable lesson: the most powerful medical technologies are sometimes the simplest, provided someone proves they work where it matters. The Bangaon data broke the professional resistance to oral therapy and gave WHO the evidence it needed to make ORS a global standard ^[5]. UNICEF's child survival campaigns of the 1980s, which drove a steep fall in deaths from diarrhoeal disease, were built directly on that foundation ^[6].

His career also reshaped how public health thinks about delivery. By handing treatment to family members and volunteers, the 1971 intervention showed that lifesaving care does not always require professionals, an insight that echoes through community health worker programmes to this day ^[4]. Scientists such as Nalin and Cash, who developed the therapy in Dhaka, have consistently acknowledged the Bangaon trial as the decisive proof of concept at scale.

In West Bengal and Bangladesh he is remembered with particular warmth, a Bengali doctor born in what became Bangladesh who saved Bangladeshi refugees on Indian soil. Institutions he touched, from the Institute of Child Health in Kolkata to ICDDR,B in Dhaka, continue the work on child survival that defined his life ^[2]. Oral rehydration therapy remains on the WHO Model List of Essential Medicines, and every packet dissolved in clean water somewhere in the world extends the experiment he ran, under the worst possible conditions, in the summer of 1971 ^[6].